ZTS

ZOETIS
D

ZTS

161.700
USD
-1.80
(-1.10%)
مفتوح الان
حجم التداول
69,154
الربح لكل سهم
6
العائد الربحي
1.1
P/E
30
حجم السوق
72,407,952,979
التوصيات
Moustafa El khaldy
Moustafa El khaldy
منذ 8 أشهر
buy
ZTS
ZTS@174.98
2024-07-08 04:45
ZTS@174.98 Chart
الربح
877.00
المزيد
أصول ذات صلة
AMGN
AMGN
3.20
(1.05%)
308.42 USD
BMRN
BMRN
-0.100
(-0.15%)
68.200 USD
E
ELAN
-0.82000
(-7.61%)
9.96000 USD
GILD
GILD
1.110
(0.99%)
113.040 USD
IDXX
IDXX
-14.51
(-3.40%)
411.74 USD
INCY
INCY
-0.270
(-0.43%)
62.050 USD
MRK
MRK
0.990
(1.14%)
87.405 USD
REGN
REGN
-2.98
(-0.48%)
622.26 USD
VRTX
VRTX
3.06
(0.63%)
486.08 USD
المزيد
الأخبار المقالات

العنوان: ZOETIS

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.